-
Did you mean
- assay development:
-
Human Growth Hormone ELISA (HGH ELISA)Catalog #: 25-HGHHU-E01
Sensitivity: 0.5 ng/mL
Range: 2.5 - 50 ng/mL
Sample Types: Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Complement System C4d ELISA
Catalog #: 13-COMPL-C4d
Sensitivity: 4.7 ng/mL
Range: 0 – 400 ng/mL
Sample Types: EDTA Plasma
Sample Size(s): 96 Wells
Detection: Colorimetric -
Total IgE ELISA
Catalog #: 25-IGEHU-E01
Sensitivity: 5.0 IU/mL
Range: 10 - 800 IU/mL
Sample Types: Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Thyroid Stimulating Hormone ELISA (TSH ELISA)
Catalog #: 25-TSHHU-E01
Sensitivity: 0.2 µIU/mL
Range: 0.5 - 25 µIU/mL
Sample Types: Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Free Triiodothyronine ELISA (Free T3 ELISA)
Catalog #: 25-FT3HU-E01
Sensitivity: 0.05 pg/mL
Range: 0.9 - 19 pg/mL
Sample Types: Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Free Thyroxine ELISA (Free T4 ELISA)
Catalog #: 25-FT4HU-E01
Sensitivity: 0.05 ng/dl
Range: 0.3 - 7.0 ng/dl
Sample Types: Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Total Thyroxine ELISA (Total T4 ELISA)
Catalog #: 25-TT4HU-E01
Sensitivity: 0.4 µg/dl
Range: 2 - 25 µg/dl
Sample Types: Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Insulin Autoantibody ELISA (IAA ELISA)
Catalog #: 21-IAAHU-E01
Sensitivity: n/a
Range: Cut-off
Sample Types: Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Parvovirus B 19 IgG ELISA
Catalog #: 20-PBGHU-E01
Range: pos./ neg. / cut off control
Sample Types: Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
L-Citrulline ELISA
Catalog #: 30-6600
Sensitivity: 6.25 µM
Range: 6.25 - 400 µM
Sample Types: Plasma, Serum, Urine
Sample Size(s): 96 Wells
Detection: Colorimetric -
TGF Beta-2 ELISA
Catalog #: 20-TGF2HU-E01
Sensitivity: 10 pg/mL
Range: 31.25 - 1000 pg/mL
Sample Types: Cell Culture, Plasma, Serum
Sample Size(s): 96 Wells
Detection: Colorimetric -
Herpes Simplex Virus 2 IgM ELISA
Catalog #: 20-H2MHU-E01
Range: pos. / neg. / cut off control
Sample Types: Serum
Sample Size(s): 96 Wells
Detection: Colorimetric
Responsibility
ALPCO’s Diabetes Research Travel GrantALPCO strives to provide scientists and healthcare professionals with robust tools for their research and clinical diagnostic endeavors. We understand that championing extraordinary discoveries requires extraordinary efforts, and support. We are proud to continu...
Life Science Research
Moving your life science research toward breakthroughs with reagents and walk-away, sample-to-answer solutionsWhether you’re doing basic or translational life science research, you need ready access to the platforms, assays, products, and other tools that are essential to your work. ALPCO has been d...
Alpco Home Page
New: Calprotectin Immunoturbidimetric Assay will take your testing to the next level. Learn more.Supporting your work with life science and clinical testing productsVIEW ALL LIFE SCIENCE PRODUCTSVIEW ALL CLINICAL DIAGNOSTIC PRODUCTS
Tips & Tricks
The Enzyme-Linked Immunosorbent Assay (ELISA) is a proven sensitive method for detecting and quantifying specific biomarkers in a wide range of clinical and research samples. The accuracy and precision of ELISAs can be affected by many factors, including pipetting, washing, and sample-handling techn...
ALPCO Releases STELLUX® Chemiluminescent Human Intact Proinsulin ELISA
ALPCO announced in a press release on February 18, 2014 that the company has launched their new STELLUX® Chemiluminescent Human Intact Proinsulin ELISA, the latest assay to be launched in the company’s STELLUX® Chemiluminescent product line. The new Human Intact Proinsulin ELISA features a broad dyn...
ALPCO to Feature New STELLUX® Chemi Active GLP-1 (7-36) amide ELISA and Young Investigators Travel Grant Program at ADA’s 78th Scientific Sessions
June 19, 2018
ALPCO, a leading producer of research and clinical immunoassays, announced it will showcase its new STELLUX® Chemi Active GLP-1 (7-36) amide ELISA at the American Diabetes Association’s 78th Scientific Sessions June 23-25, 2018 in Orlando, FL. This new addition to the STELLUX® Chem...
Complement System Solutions for Drug Development and Clinical Research
Datasheet: Complement System Immunoassays
Download
The complement system is essential to innate immunity which protects from chronic, autoimmune, and infectious disease. There are three distinct pathways of complement activation: classical, lectin/MBL, and alternative. Each leads...
Role of IGF-1 in the Growth Hormone/IGF Axis
The Growth Hormone/IGF axis consists of IGF-1, IGF-2 and several high and low affinity IGF Binding Proteins (IGFBP). The whole system is tightly regulated by a feedback loop involving Growth Hormone (GH) secreted by the pituitary, and GH production and secretion controlled by Growth Hormone Releasin...
Bone Metabolism: The Cycle of Bone Growth and Resorption
Bone metabolism is a continual cycle of bone growth and resorption that is carefully orchestrated by the dynamic relationship between osteoclasts, osteoblasts and an array of hormonal and regulatory influences. The relative levels of these signaling molecules dictate whether healthy, balanced bo...
Toxicology
Drug-Induced Organ Injury
Toxicological side effects are a common obstacle in drug development pipelines and often manifest in site-specific damage to vital organs, including the liver, kidney and heart. Estimates of compound attrition from failure to meet safety endpoints are as high as 45% in pre...
ALPCO and InSphero Collaborate to Advance Metabolic Disease Research at ADA 2017
Date: June 6, 2017
ALPCO announced it will collaborate with InSphero, a supplier of 3D cell culture solutions, at the ADA’s 77th Scientific Sessions June 10-12 in San Diego. Together, ALPCO and InSphero aim to enhance the study of islet function, regeneration, and preservation by providing resear...
Investigating Immunogenicity of IBD Biologics
Biologics have been commonly prescribed as therapies for inflammatory bowel disease (IBD) since the late 1990s. However, research demonstrates that not all individuals respond to the first biologic taken and many lose response over time1. As a result, there is a great need to explore the immunogenic...
Researching Therapeutic Drug Monitoring for IBD
Multiple classes of biologics are available for the treatment of inflammation associated with inflammatory bowel disease (IBD) which ultimately improves the quality of life for patients. However, many challenges are associated with using biologics to treat IBD such as immunogenetic reactions and th...
Therapeutic Drug Monitoring of Biosimilars in Autoimmune Diseases
Anti-TNF-alpha biologics have been proven to be effective treatments for autoimmune diseases such as rheumatoid arthritis (RA) and inflammatory bowel disease (IBD)1. Rising healthcare costs as well as patent expirations, however, have prompted the development of biosimilars, such as the infliximab b...
Terminal Complement Complex (TCC) ELISA Now Available
ALPCO now offers an ELISA to measure the concentration of TCC (sC5b-9) levels in human plasma; an essential step to evaluate whether foreign materials in contact with blood are triggering an immune response. The Complement TCC ELISA is easy-to-use with a 2-hour incubation and reflects complement act...
Featured Biomarkers from A to Z
This handout briefly describes the role of several important hormones measured in research.
ELISAs for CHO Host Cell Proteins
Chinese Hamster Ovary (CHO) cells are the most dependable and most popular host cells for the industrial production of biotherapeutics. They are stable cell lines that are adaptable to a wide range of culture conditions and routinely produce very high protein and antibody yields. More importantly,...
Live Webinar: Optimizing IBD Management with Fecal Calprotectin - From Diagnosis to Monitoring
In the webinar, Dr. Benjamin Click from the University of Colorado, Department of Gastroenterology, underscores the critical role of non-invasive monitoring methods, particularly fecal calprotectin monitoring, in guiding treatment adjustments and achieving therapeutic goals..
Differentiating Gastrointestinal Pathogens from IBD and IBS
Gastrointestinal (GI) disorders such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS), as well as infections from GI pathogens can present very similar symptoms. A host of tests have been developed to aid in the differentiation between IBD and IBS, such as calprotectin and lact...
ALPCO Releases New Chemiluminescent Human C-peptide ELISA
ALPCO announced the launch of its new STELLUX® Chemiluminescent Human C-peptide ELISA on December 5, 2014. This highly characterized assay measures C-peptide requiring only 50 µL of human serum, plasma or cell culture supernatant. The ELISA exhibits greater sensitivity and a broader dynamic range co...
CisBio's Chromoa® Chromogranin A ELISA
Chromoa®
The Chromoa® Chromogranin A ELISA from Cisbio Bioassays is for the quantitative determination of CgA in serum and plasma. The patented monoclonal detection system provides superior specificity, sensitivity and reproducibility to determine elevated serum CgA levels. Above all, the hook effe...
ALPCO and Cisbio US, Inc. Announce Sales and Distribution Agreement
Date: July 1, 2015
ALPCO is pleased to announce a strategic account sales and distribution agreement with Cisbio US, Inc. Cisbio will now have exclusive access to ALPCO’s high quality STELLUX® Chemiluminescence and colorimetric Diabetes and Obesity assay portfolio in order to provide these produc...
Simplify Stool Sample Processing
Introduction
We understand the challenges facing lab managers and directors who need to continuously improve workflow efficiency and implement new tests and technologies to be competitive. Our unique extraction method can be used with a portfolio of targeted stool markers. This allows your lab to s...
New Stool-Based Gastroenterology Assays and Extraction Method Can Improve Lab Sample Processing Time By Up To 86%
Date: January 26, 2016
ALPCO recently launched a new panel of 13 stool-based gastroenterology assays that are all compatible with one single extraction step. The unique extraction method allows laboratories to improve their sample processing time by up to 86% by extracting one sample for up to 13...